Your browser doesn't support javascript.
loading
Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Kresse, Stine H; Brandt-Winge, Sara; Pharo, Heidi; Flatin, Bjørnar T B; Jeanmougin, Marine; Vedeld, Hege Marie; Lind, Guro E.
Afiliação
  • Kresse SH; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
  • Brandt-Winge S; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
  • Pharo H; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
  • Flatin BTB; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
  • Jeanmougin M; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
  • Vedeld HM; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
  • Lind GE; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway. guro.elisabeth.lind@rr-research.no.
Clin Epigenetics ; 15(1): 151, 2023 09 14.
Article em En | MEDLINE | ID: mdl-37710283

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Nucleicos Livres / DNA Tumoral Circulante / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Epigenetics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Nucleicos Livres / DNA Tumoral Circulante / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Epigenetics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega